WHO designates Shan5 prequalified

|By:, SA News Editor

The World Health Organization extends "prequalification status" to Sanofi's (SNY +0.6%) Shan5 vaccine. This allows United Nations agencies like UNICEF to purchase the product.

Sanofi developed Shan5 with the Indian biotech firm Shantha. It was cleared for sale in that country in March.

The vaccine protects children from diptheria, tetanus, pertussis, Hib and hep B.